(MedPage Today) — MONTREAL — An investigational bispecific antibody for retinal disease achieved faster and numerically greater short-term improvements in visual acuity and retinal anatomy versus faricimab (Vabysmo), a randomized, proof-of…
Source: MedPage Today — Headlines
